Sensyne Health plc announced earnings results for the half year ended October 31, 2019. For the half year, the company announced sales was GBP 392,000 compared to GBP 39,000 a year ago. Operating loss was GBP 9.837 million compared to GBP 10.334 million a year ago. Net loss was GBP 9.894 million compared to GBP 13.309 million a year ago. Basic loss per share from continuing operations was GBP 0.08 compared to GBP 0.1 a year ago.